These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10560958)

  • 1. Papillary thyroid carcinoma metastatic to the pituitary gland.
    Masiukiewicz US; Nakchbandi IA; Stewart AF; Inzucchi SE
    Thyroid; 1999 Oct; 9(10):1023-7. PubMed ID: 10560958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular thyroid carcinoma with metastases to the pituitary causing pituitary insufficiency.
    Vianello F; Mazzarotto R; Taccaliti A; Lora O; Basso M; Servodio O; Mian C; Sotti G
    Thyroid; 2011 Aug; 21(8):921-5. PubMed ID: 21595558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism.
    Ringel MD; Ladenson PW
    J Clin Endocrinol Metab; 1996 May; 81(5):1724-5. PubMed ID: 8626823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated thyrotropin deficiency secondary to primary empty sella in a patient with differentiated thyroid carcinoma: an indication for recombinant thyrotropin.
    Colleran KM; Burge MR
    Thyroid; 1999 Dec; 9(12):1249-52. PubMed ID: 10646666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
    Rudavsky AZ; Freeman LM
    J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
    [No Abstract]   [Full Text] [Related]  

  • 6. Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma.
    Shakir MK; Krook LS; Schraml FV; Hays JH; Clyde PW
    Thyroid; 2008 Jul; 18(7):787-92. PubMed ID: 18631009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
    Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human thyrotropin in thyroid cancer and hypopituitarism due to sella metastasis.
    Risse JH; Grünwald F; Bender H; Schüller H; Van Roost D; Biersack HJ
    Thyroid; 1999 Dec; 9(12):1253-6. PubMed ID: 10646667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of TSH rise prior to radio-iodine therapy for thyroid cancer: implications for treatment.
    Nutting C; Hyer S; Vini L; Harmer C
    Clin Oncol (R Coll Radiol); 1999; 11(4):269-71. PubMed ID: 10473725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary carcinoma of thyroid metastatic to the pituitary gland.
    Bell CD; Kovacs K; Horvath E; Smythe H; Asa S
    Arch Pathol Lab Med; 2001 Jul; 125(7):935-8. PubMed ID: 11419981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal metastases from papillary thyroid carcinoma.
    Sardi A; Agnone CM; Pellegrini A
    J La State Med Soc; 1992 Sep; 144(9):416-20. PubMed ID: 1402321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii.
    Rotman-Pikielny P; Reynolds JC; Barker WC; Yen PM; Skarulis MC; Sarlis NJ
    J Clin Endocrinol Metab; 2000 Jan; 85(1):237-44. PubMed ID: 10634393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between recombinant human thyrotropin stimulation and prolonged levothyroxine withdrawal.
    Frigo A; Dardano A; Danese E; Davì MV; Moghetti P; Colato C; Francia G; Bernardi F; Traino C; Monzani F; Ferdeghini M
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3472-6. PubMed ID: 19509107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.
    Taïeb D; Sebag F; Farman-Ara B; Portal T; Baumstarck-Barrau K; Fortanier C; Bourrelly M; Mancini J; De Micco C; Auquier P; Conte-Devolx B; Henry JF; Mundler O
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3283-90. PubMed ID: 20392868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal.
    Pacini F; Molinaro E; Castagna MG; Lippi F; Ceccarelli C; Agate L; Elisei R; Pinchera A
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4063-8. PubMed ID: 12213846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
    Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
    Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic ovarian metastasis from papillary thyroid carcinoma: a case report.
    Logani S; Baloch ZW; Snyder PJ; Weinstein R; LiVolsi VA
    Thyroid; 2001 Nov; 11(11):1073-5. PubMed ID: 11762718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience.
    Perros P
    J Endocrinol Invest; 1999; 22(11 Suppl):30-4. PubMed ID: 10727003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
    Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.